Company intelligence / Profile preview

Shore Heart Group

Neptune, NJ, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Shore Heart Group is a leading cardiology practice in New Jersey, providing comprehensive cardiac care including interventional cardiology, electrophysiology, and nuclear cardiology. The group operates seven clinics with over 20 board-certified physicians and has been serving the region for more than two decades. In June 2023, it was acquired by Cardiovascular Associates of America (CVAUSA), expanding its reach as part of a larger national network.

Therapeutic areas: CardiovascularNeurology
Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Cardiovascular Associates of America

Beyond the preview

Go deeper on Shore Heart Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shore Heart Group.

Explore the full profile